CRENTSIL HEALTH SOLUTIONS LTD

Executive Summary

Crentsil Health Solutions Ltd is a newly formed pharmaceutical consultancy with a strong initial liquidity position and positive working capital, indicating short-term financial health. However, its very small operational scale and limited financial history necessitate careful growth management and improved financial transparency to ensure sustainable development. With focused efforts on revenue generation and prudent cash management, the company has a reasonable outlook for financial stability going forward.

CRENTSIL HEALTH SOLUTIONS LTD - Analysis Report

Company Number: 15046929

Analysis Date: 2025-07-29 14:16 UTC

Financial Health Assessment: CRENTSIL HEALTH SOLUTIONS LTD

---

1. Financial Health Score: B-

Explanation:
The company is newly incorporated (August 2023) and has filed its first set of accounts for the year ended August 2024. Given its early stage, the financial data is limited but shows initial positive signs such as a positive net current asset position and shareholder funds. However, the very low asset base and minimal operational scale (one employee, very small cash and debtors) reflect the company is in a nascent phase, making it vulnerable to operational shocks. The B- score reflects a cautious optimism with a need for growth and closer monitoring.

---

2. Key Vital Signs

Metric	Value	Interpretation
Incorporation Date	August 2023	Very young company; limited financial history
Account Category	Small (Total Exemption Full)	Filing small company accounts, no audit required
Current Assets	£148	Extremely low; limited liquidity buffer
Cash	£147	Almost entire current assets held in cash - good immediate liquidity
Debtors	£1	Negligible trade receivables
Current Liabilities	£(167)	Creditors due within one year
Net Current Assets	£315	Positive working capital, indicating ability to cover short-term debts
Shareholders Funds	£315	Equity capital invested and retained earnings
Number of Employees	1	Minimal operational scale
Director & PSC	Mr Kwamena Sagoe Crentsil (100% control)	Sole control and responsibility, concentrated decision-making
Industry SIC Code	74909 - Other professional, scientific and technical activities not elsewhere classified	Specialized consultancy services

---

3. Diagnosis: Financial Health and Business Condition

• Healthy Cash Flow Symptom: The company holds nearly all current assets as cash (£147) with no significant receivables, indicating a clean and healthy cash position for immediate operational needs. This suggests no current cash flow distress.

• Symptoms of Limited Scale and Growth Stage: The very low absolute figures in assets and liabilities, combined with just one employee and director, indicate the company is at a start-up or early development stage rather than a mature operating business.

• Positive Working Capital: Net current assets of £315 show the company can comfortably meet its short-term obligations, a good sign of solvency in the short term.

• Lack of Profit & Loss Account Details: The absence of reported turnover or profit data limits insight into operational performance and profitability. The company elected to omit the profit and loss account in the filing, which is allowed under small company exemptions but reduces transparency.

• Equity and Capitalisation: Shareholders funds of £315 reflect initial share capital and retained earnings or profits, indicating some level of capitalization but very modest in scale.

• Governance and Control: Single director and sole person with significant control (PSC) means decision-making is concentrated, which may be efficient but also a risk if expertise or oversight is limited.

• Industry Risks: Operating in a niche consultancy field (pharmaceutical consultancy) can be lucrative but also demands specialized skills, client acquisition, and reputation building, all challenging for a new entity.

---

4. Recommendations: Improving Financial Wellness

• Develop Revenue Streams & Profitability: Focus efforts on securing consultancy contracts or clients to generate consistent revenue and build a profit track record. Early revenue generation is critical to transition from start-up phase.

• Maintain Healthy Cash Reserves: Continue prudent cash management to preserve liquidity. Avoid overextending credit or incurring liabilities beyond immediate capacity to pay.

• Financial Reporting Transparency: Consider including profit and loss accounts in future filings to enhance transparency for stakeholders and build confidence with lenders or investors.

• Build Operational Capacity: As business grows, plan for gradual expansion in staff or technical resources to meet client needs and diversify operational risk.

• Governance and Oversight: If possible, involve additional directors or advisors to provide broader oversight and strategic input, reducing risks from concentrated control.

• Monitor Working Capital Regularly: Keep tight control over payables and receivables to sustain positive net current assets and avoid liquidity issues.

• Strategic Planning: Develop a clear business plan outlining growth targets, market positioning, and financial projections to guide operations and attract potential investment if needed.

---